Tryck

I am long since 2-3 years now and it is becoming more and more painful to watch. Though I still believe in the Biocartis value proposition and unique selling point. If they come with anything less tha...

I find it strange that the price is struggling to get above €5, seems there is a lot of resistance to break through that ... Even though the fundamentals and news flow has been quite positive lately. ...

Pre-earnings stress :p...

BCART re-confirmed the 2020 guidance based on the assumption there would be no new lock-downs ... I wonder how the new imposed semi-lockdown across Europe will impact Q4 and further guidance.What ...

@Matsversch : Emergency use approval kan elk moment aangekondigd worden :)...

Ondertussen is Q3 toch al bijna afgelopen (eind September).Het feit dat ze de outlook terug bevestigen is toch geruststellend wat wil zeggen dat de situatie in Q3 toch al flink hersteld is.De co...

Het is een geruststelling om te zien dat ze hun 2020 guidance opnieuw hebben bevestigd. Laten we niet vergeten dat de hele wereld in lockdown zat tijdens Q2 - dus dan lijken de cijfers op het eerste...

@FL it seems like you and I had a simultaneous moment of similar thoughts and worries.Cash burn figures and new guidance / projections will be welcomed.Time for BCART to step up....

It looks like they are really going to make us wait until September 3rd for any updates... Its only 2 weeks away from now, so I guess they are just holding all the news for the Q2 u...

So theyre having an extraordinary shareholders meeting to vote on a capital increase without the issue of new shares but by use of share premiums, immediately followed by a capital decrease ...

hey FL,Thanks for clarifying . I was not aware of this Paradigm acquisition and it indeed raises some question marks about where Exas puts its priorities (NGS / IVD) and the silence around Idylla ...

FL,A few days ago you wrote rather skeptical about the Exas Oncotype DX (Breast Prostate) partnership.What is it exactly that makes you question the partnership, I assume there are multiple ...

Interesting developments! Though the market does not really seem to respond to the news. Then again, 600K $ is indeed peanuts in this market, as FL mentions.Q2 is coming to an end on 30 Ju...

From LinkedIn:Check out the Idylla™ ASCO20 abstracts! Showing strong data of Idylla™ tests, as well as first Idylla™ data from China with MSI and EGFR tests! lnkd.in/gUg8m_m...

investors.biocartis.com/sites/default...investors.biocartis.com/sites/default...

Uit De Tijd: Begin deze week hield Belfius een online roadshow met de CEO van Biocartis (Herman Verrelst, red.) en dat verliep erg soepel. Nergens elders vind ik hierover enige vermelding though. ...

I read many people are taking some profits, congratulations for all who sticked with Biocartis during the rough past year; I am finally in the green again.I believe the next 9-12 months provide su...

De nieuwe CFO is geruststellend. Hopelijk gaan we onze broek niet scheuren aan die Covid-19 test, maar als dit goed gaat zou het een katalysator kunnen zijn om Biocartis wereldwijd op de kaart te ...

@FL, good point@wakeman: Op donderdag geeft Bcart een kwartaalupdate (Q1 ending 31 maart) . Ik ben alvast benieuwd naar business updates, outlook / corona impact en eventuele communicatie over...

An interesting 1-pager shared on Biocartis LinkedIn page showing the “Impact of In-House Biomarker Testing on Non-Small Cell Lung Cancer Patients” presented @ USCAP by William Osler Health System, Can...

Reading into the Biocartis prospectus from 2015 I read that Biocartis in the past was focussed on1: oncology 2: infectuous diseasesI understand that at some point Biocartis shifted strategy an...

Ik denk dat het nog een aantal weken zal duren voor we de bodem van deze crisis bereikt hebben, nu veel landen elk op hun beurt beschermende maatregelen treffen....

degette.house.gov/media-center/press-...[b] In addition to permanently removing the pre-approval requirement for ...

www.politico.com/newsletters/prescrip...BIPARTISAN BILL TO OVERHAUL LAB TESTS LANDS — A bipartisan, bicameral grou...

Same story here ... Mijn positie in BCART is al te groot in verhouding met mijn totale portefeuille, hoewel de verleiding groot is om veel bij te kopen.Ik heb nog 100 stuks bijgekocht aan 4.65; di...

FLCorrect, net financial expenses amount up to € 7,9 million during the year; and include: - the convertible bond for EUR 5,2 miljoen ( EUR 3,0 miljoen coupon EUR 2,2 miljoen debt valuatio...

Mijn mening: 30% verwachte groei is mooi. Een voorzichtige outlook bestaat er om overtroffen te worden.Wat me een klein beetje stoort is dat ze altijd spreken over groei aantal installed base en car...

[quote alias=Flatlander id=12159488 date=202002271450]TyrckYouth, is the exception. I think in 10 years you will be happy that you speculated as you did. I have no fear of BCART failing techni...

FL, I understand the speculative nature of my portfolio at the moment. I think my current position of 40% is as far as I want to go. To put it into perspective I am 25 and my total investment port...

I think (and I hope) these are times which create exceptional buying opportunities for Biocartis... at least thats what I did the past two days. I added positions at 5.5€ and 5€. Though I need ...

Some good input around Genomic Health, @Flatlander, thanks. Patience will pay off in the long run ... ...

Only a brief reference to OncoType in the earnings transcript call of EXAS:[i]Kevin Conroy (CEO)[...]During the quarter, we closed the Genomic Health acquisition. As a combined company,...

[quote alias=Tryck id=12108291 date=202002090920]Interessant artikel in de Tijd www.tijd.be/ondernemen/farma-biotech/...[b]...

Interessant artikel in de Tijd www.tijd.be/ondernemen/farma-biotech/...Vroege kankersignalen zie je al jaren of zelfs decenni...

In de kwartaalupdate geven ze een korte update over de fabriek in Spartanburg die eraan komt (50-50 Joint Venture met Indorama).www.irdirect.net/prviewer/release/id/...Voorlopig bl...

Als je op € 5.47 gekocht hebt en aan € 6.34 kan verkopen de volgende dag heb je een kleine 16% winst, dit is puur korte termijn mensen die winst nemen - is logisch en ik zou hetzelfde doen als ik niet...

Toch pijnlijk die koersdalingen ... ik ben ingestapt aan €12 rond mei/juni 2018 en heb telkens pakketjes bijgekocht na de koersval. Het lezen van de vele informatie op dit forum en het potentieel ...